56 studies found for:    "Hereditary angioedema"
Show Display Options
RSS Create an RSS feed from your search for:
"Hereditary angioedema"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Drug: Ecallantide subcutaneous dosing
2 Recruiting A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: Low-volume C1-esterase inhibitor;   Biological: Higher-volume C1-esterase inhibitor;   Biological: Low-volume placebo;   Biological: Higher-volume placebo
3 Completed Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Intervention: Drug: C1 esterase inhibitor [human] (C1INH-nf)
4 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
5 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
6 Recruiting A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: icatibant
7 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
8 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
9 Completed
Has Results
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
10 Completed
Has Results
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Tranexamic Acid;   Drug: Oral Placebo;   Drug: S.C. Placebo
11 Withdrawn Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Biological: ecallantide
12 Recruiting A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention:
13 Completed
Has Results
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Conditions: Hereditary Angioedema;   Angioneurotic Edema;   Genetic Disorders
Interventions: Drug: recombinant human C1 inhibitor;   Drug: Placebo
14 Completed
Has Results
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Conditions: Hereditary Angioedema;   Angioneurotic Edema
Interventions: Drug: Recombinant Human C1 Inhibitor;   Drug: placebo
15 Completed
Has Results
CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
16 Recruiting Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Interventions: Drug: DX-2930;   Drug: Placebo
17 Completed
Has Results
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS), pH 7.0
18 Completed Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
19 Recruiting Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
20 Completed
Has Results
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS),

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years